[vc_row full_width=”stretch_row” css=”.vc_custom_1521558919207{margin-top: -75px !important;margin-bottom: 0px !important;padding-top: 120px !important;padding-bottom: 0px !important;}”][vc_column width=”3/4″][vc_custom_heading source=”post_title” use_theme_fonts=”yes”][vc_column_text css=”.vc_custom_1520593077857{margin-bottom: 25px !important;}”][/vc_column_text][vc_column_text]
- 15/07/2022-29/04/2024
Biogena (A.P.I) LTD has earned within the contexts of the operational program «Θ.Αλ.Ε.Ι.Α» 2021-2027 a public funding for the implementation of it. Through this program, the company will invest in the purchase of new LC-MS/MS.
‘The Project is funded by the European Union through the Ministry of Energy, Commerce and Industry’
[/vc_column_text][vc_empty_space height=”30px”][vc_column_text]
- Development and Scale-Up Manufacturing of Therapeutic Peptides (CYTIDES), CODEVELOP-ICT-HEALTH/0322/0038
First time in Cyprus that Academia and an API (Active Pharmaceutical Ingredient) manufacturer collaborate towards the co-development of generic therapeutic peptides.
CYTIDES enhances the effective collaboration between the pharma industry (BIOGENA API) and the research community (Laboratory of Peptide Chemistry – University of Nicosia Research Foundation – UNRF) in innovative technologies sharing knowledge, resources, and infrastructures.
‘The Project is funded by the European Union – NextGenerationEU, through the Research and Innovation Foundation’
[/vc_column_text][vc_empty_space height=”20px”][vc_column_text]
- 14/12/2022-13/06/2023
Green techniques in peptide synthesis, INNOVOUCHER/0722/0009
Biogena A.P.I Ltd in collaboration with the Laboratory of Peptide Chemistry – University of Nicosia Research Foundation – UNRF have been funded for a project under the Technological Development and Innovation “RESTART 2016 – 2020”.
‘The Project is funded by the European Union – NextGenerationEU, through the Research and Innovation Foundation’
[/vc_column_text][vc_empty_space height=”20px”][vc_column_text]
- Innovative drug formulation for targeted release of Rifaximin based on polymer nanotechnology (INNOVATE/0719/0083)
Biogena A.P.I Ltd in collaboration with Medochemie Ltd (a generic pharmaceutical company) have been funded for a project under the Technological Development and Innovation “RESTART 2016 – 2020”.
‘The Project is funded by the European Union – NextGenerationEU, through the Research and Innovation Foundation’
[/vc_column_text][vc_empty_space height=”20px”][/vc_column][vc_column width=”1/4″][stm_sidebar sidebar=”311″][/vc_column][/vc_row][vc_row full_width=”stretch_row” disable_element=”yes” css=”.vc_custom_1520589643234{padding-top: 44px !important;padding-bottom: 44px !important;background-color: #f2f2f2 !important;}”][vc_column][stm_image_carousel grayscale=”yes” img_size=”180×96″ items_mobile=”2″ images=”1459,1459,1459,1459,1459,1459″ custom_links=”/company-overview/our-partners/,/company-overview/our-partners/,/company-overview/our-partners/,/company-overview/our-partners/,/company-overview/our-partners/”][/vc_column][/vc_row][vc_row full_width=”stretch_row” el_class=”third_bg_color” css=”.vc_custom_1520589649429{margin-bottom: -60px !important;}”][vc_column][vc_cta h2=”are you interested in more information?” h2_font_container=”font_size:20px|color:%23000000|line_height:24px” h2_use_theme_fonts=”yes” shape=”square” style=”flat” add_button=”right” btn_title=”get in touch” btn_style=”flat” btn_color=”theme_style_2″ btn_align=”right” btn_i_align=”right” btn_i_icon_fontawesome=”fa fa-chevron-right” use_custom_fonts_h2=”true” btn_button_block=”true” btn_add_icon=”true” el_class=”third_bg_color” css=”.vc_custom_1521708501074{margin-bottom: 0px !important;}” btn_link=”url:%2Fcontact-us%2F|||”][/vc_cta][/vc_column][/vc_row]